Novel 2’-O-Ethyl-capped RNA showed higher expression than natural Cap1 RNA, and slower clearance rate in vivo.
最速3週間で遺伝子からmRNAまで、最先端なmRNA、環状RNA、自己増幅型RNA技術をLNPデリバリーシステムとシームレスに統合して、お客様のイノベーションを推進します。
革新を推進する
最先端のmRNA、環状RNA、自己増幅型RNA技術が、LNPデリバリーシステムとシームレスに統合されています。
GenScriptのIVT mRNA製造ソリューションは、遺伝子合成からmRNA生産までのワークフローを簡略化します。当社のIVT mRNAは、独自の生産プラットフォームで最適化されており、品質と発現効率が保証されています。
コドン/UTR
最適化
遺伝子合成
クローニング/
プラスミド調製
mRNA
合成
脂質ナノ粒子デリバリー
| 直鎖状RNA | 自己増幅型RNA | 環状RNA | |||||
![]() |
![]() |
![]() |
|||||
| 構造 | 直鎖状、5'末端と3'末端が露出する エキソヌクレアーゼによる分解を受け易い | 直鎖状、5'末端と3'末端が露出する エキソヌクレアーゼによる分解を受け易い | 閉じた環状構造で、遊離した5ʻ末端や3ʼ末端が無い エキソヌクレアーゼによる分解を受け難い | ||||
| リボソームの動員 | 5ʼ Capが翻訳開始に寄与し、mRNAを 安定化させる | 5ʼ Capが翻訳開始に寄与し、 mRNAを安定化させる | IRES (Internal Ribosome Entry Site) が翻訳開始に寄与する | ||||
| ORF |
|
|
|
||||
| UTR | 5ʻと3ʼのUTR構造はmRNAの安定性や翻訳促進に寄与 | mRNAの自己複製を促進するレプリコンを含む | IRES、PIE、およびその他エレメント を含む | ||||
| PolyA tail | RNA分子の分解を抑制し、安定化する | RNA分子の分解を抑制し、安定化する | 不要 | ||||
| タンパク質発現 | +++ 強い | +++++ 最も強い | ++++ より強い | ||||
| 発現半減期 | +++ より短い | +++++ 最も長い | ++++ より長い | ||||
| 免疫原性 | ++++ 低い | ++ 高い | +++ 中程度 | ||||
| 投与量要件 | ++ 高い | +++++ 最も低い | +++ 中程度 | ||||
| 新規性 | +++ 従来型 | ++++ 新規 | +++++ 新規 | ||||
Novel 2’-O-Ethyl-capped RNA showed higher expression than natural Cap1 RNA, and slower clearance rate in vivo.
We can make mRNA from 100bp to 20kb in length. For oligo shorter than 100bp, our oligo synthesis team can take it under chemical syntehsis.
For RUO grade mRNA, we use silica membrane or LiCl precipitation method for purification. It is suitable for in vitro and invivo proof of concept studies.
For preclinical grade, we use HPLC based Oligo dT purification for improving RNA purity. Preclinical grade can be considered for long mRNA constructs >5kb or when high RNA purity (less fragment RNA ) is required for the project.
We can provide cGMP mRNA through our sister company ProBio. Please contact our technical support team.
Yes. We guarantee specific amounts of mRNA be delivered.
We ship mRNA at concentration of 0.5 ~2mg/mL by default. We can adjust concentration to a specific value <4mg /mL per customer's request at extra cost.
Dr. Sean Whelan
Washington University School of Medicine
Contracting with Genscript for the production of mRNA-LNPs has advanced my laboratory's research into viral vaccines by allowing us to rapidly produce and test multiple mRNA vaccine constructs for several different viruses. We appreciate Genscript's easy ordering processing, and diverse options for mRNA format and LNP encapsulation strategy.
Dr. Mahdi Zeraati
University of Sydney
We have used their IVT mRNA synthesis, FLASH gene synthesis, and TurboCHO antibody production platforms across several projects, and each has consistently met our expectations. Notably, GenScript successfully synthesized a challenging, repeat-rich gene that other providers declined to undertake, demonstrating their technical capability and commitment to supporting complex research needs.
Chun-YuChen
Seattle Children's Hospital
I purchased mRNA from different companies and found that GenScript's mRNA showed higher expression (almost 2 fold) and much more cost effective!!
Dr. Sang-Moo Kang
Institute for Biomedical Sciences at Georgia State University
GenScript mRNA has helped us make a rapid progress in developing novel vaccine projects. GenScript's service is faithful and timely provided, saving me lots of time to focus on research. This is why I have been using GenScript services for over 20 years.
Zack Ho
R&D Manager at Lion TCR Pte Ltd
We have utilized GenScript's gene and mRNA synthesis service for our research projects, and the outcomes have been exceptional. The product quality, timely delivery, and technical support have consistently surpassed our expectations.
mRNA Case Study Report
Case studies showing high expression efficiency of GenScript’s mRNA for expressing SB transposase, GFP, Luciferase, eSpCas9, and more.
Free Download
Circular RNA Case Study Report
Circular RNA introduction, GenScript offering details, and case studies showing increased stability, prolonged expression, and lower immunogenicity compared to linear IVT mRNA.
Free Download
LNP Case Study Report
Case studies demonstrating encapsulation and delivery efficiency of GenScript’s new LNP formulations in cell models, and mouse models via both IM and IV.
Free Download
Critical Consideration in Sourcing mRNA_Whitepaper
This whitepaper provides valuable insights into the essential factors that vaccine and therapy developers should consider when exploring mRNA solutions
Free Download
Advancements in mRNA manufacturing_eBook
Get GenScript’s free application eBook on therapeutics development with mRNA manufacturing solutions
Free Download
mRNA Therapy Modalities_Infographic
Learn about key structural features and functions of IVT mRNA and LNP, therapeutic modalities beyond prophylactic vaccines, mRNA candidates progressing through clinical trials.
Free Download
mRNA Parts_Infographic
Learn about the main structural components of mRNA, the functional roles of each part, what constitutes high-quality IVT mRNA and more.
Free Download
Circular RNA Beginner’s Guide_Infographic
Learn about key structural components of circRNA, the process by which circRNA is translated into protein, and more.
Free Download
Self-Amplifying RNA Beginner’s Guide_Infographic
Learn about key structural components of saRNA, the processes by which saRNA replicates and is translated into protein, and more.
Free Download